| n (%)* | ||
Demographics | All patients (n = 2005) | Disease-free at death /alive (n = 1499)** | Disease related death (n = 376)** |
Gender Female Male |
805 (40) 1200 (60) |
621 (41) 878 (59) |
137 (36) 239 (64) |
Diagnosis Adenocarcinoma Other Cancer |
1977 (99) 28 (1) |
1485 (99) 14 (<1) |
367 (98) 9 (2) |
Operation Biopsy Other Resection |
108 (5) 34 (2) 1863 (93) |
36 (2) 14 (<1) 1449 (97) |
50 (13) 19 (5) 307 (82) |
Age ≤70 >70 |
1008 (50) 997 (50) |
774 (52) 725 (48) |
173 (46) 203 (54) |
Metastasis at presentation | 139 (7) | 74 (5) | 65 (17) |
Staging |
|
|
|
Dukes stage A B C1 C2 D |
209 (10) 415 (21) 358 (18) 76 (4) 7 (<1) |
190 (13) 342 (23) 236 (16) 41 (3) 2 (<1) |
15 (4) 56 (15) 96 (26) 30 (8) 5 (1) |
T stage T1 T2 T3 T4 |
106 (5) 341 (17) 1229 (61) 122 (6) |
93 (6) 300 (20) 919 (61) 78 (5) |
7 (2) 28 (7) 242 (64) 26 (7) |
N stage N0 N1 N2 |
952 (48) 462 (23) 289 (14) |
823 (55) 335 (22) 158 (11) |
87 (23) 93 (25) 104 (28) |
M stage M0 M1 |
284 (14) 104 (5) |
197 (13) 51 (3) |
63 (17) 39 (10) |
Treatment Surgery only Surgery and CT Surgery and RT Surgery and RT and CT |
971 (48) 700 (35) 51 (3) 226 (11) |
822 (55) 474 (32) 28 (2) 149 (10) |
109 (29) 172 (46) 16 (4) 59 (16) |
Follow up |
|
|
|
Dead Alive | 620 (31) 1385 (69) | 114 (8) 1385 (92) | 0 376 (100) |
Cause of death Not cancer related Cancer related Alive |
114 (6) 376 (19) 1385 (69) |
114 0 1385 |
0 376 0 |
Relapse 1 relapse 3 relapses |
477 (24)
|
183 (12)
|
243 (65)
|
Nodes examined (median [range]) | 14 (0 - 66) | 14 (0 - 56) | 12 (0 - 66) |
Positive nodes (median [range]) | 0 (0 - 31) | 0 (0 - 27) | 2 (0 - 25) |